Hamburg has acquired a Leibniz Science Campus named InterACt or “integrated analysis of pathogen-induced compartments”. This co-operative project will strengthen links between the Heinrich Pette Institute Leibniz Institute for Experimental Virology (HPI) and the University of Hamburg in the field of structural systems biology and infection research, a press release said Wednesday (April 3, 2019). The four-year InterACt project, which will launch on May 1, 2019, has been earmarked for EUR 6.6 million in funds.
Researching course of infections
InterACt will allow researchers to investigate the role of reaction chambers in cells. These chambers are enclosed areas within cells in which, for instance, special metabolic processes take place. During the course of a cellular infection, pathogens often use these niches for specific stages of their life cycles. InterACt’s goal is to study the processes and structures in these reaction chambers and to find new therapeutic approaches in the long-term. Four new research groups will be set up to deal with topics at the interface between virology and integrative data analysis.
Boosting university and non-university research
Prof. Dr. Dr. h. c. Dieter Lenzen, President of the University of Hamburg, said: “The creation of a new Leibniz Science Campus devoted to infection research is yet another example of the excellent co-operation between the university and non-university research institutions. This co-operation is promising. Together, we in Hamburg want to tackle the numerous pathogens.” Over the next four years, InterACt will receive a total of EUR 6.6 million in funding of which the University of Hamburg will contribute EUR 2.8 million, HPI will contribute roughly EUR 1.5 million, the Hamburg Ministry of Science, Research and Equalities will contribute EUR 1.2 million and the Leibniz Association will contribute EUR 1.1 million.
Sources and further information: